company background image
DRREDDY logo

Dr. Reddy's Laboratories NSEI:DRREDDY 주식 보고서

최종 가격

₹1.19k

시가총액

₹993.4b

7D

-0.3%

1Y

3.0%

업데이트

28 Nov, 2024

데이터

회사 재무 +

Dr. Reddy's Laboratories Limited

NSEI:DRREDDY 주식 보고서

시가총액: ₹993.4b

DRREDDY 주식 개요

닥터 레디 래버러토리즈는 자회사와 함께 전 세계적으로 통합 제약 회사로 운영되고 있습니다. 자세한 내용

DRREDDY 기본 분석
눈송이 점수
가치 평가3/6
미래 성장0/6
과거 실적2/6
재무 상태6/6
배당금5/6

보상

주가수익률( 18.6 x)이 Indian 시장( 31.6 x)보다 낮습니다.

지난 5년 동안 수입이 매년 27.1% 증가했습니다.

0.67% 의 안정적인 배당금을 지급합니다.

동종업계 및 업계 대비 좋은 가치로 거래

위험 분석

수익은 향후 3년간 연평균 1% 씩 감소할 것으로 예상됩니다.


Dr. Reddy's Laboratories Limited 경쟁사

Zydus Lifesciences

NSEI:ZYDUSLIFE

₹954.6b

Torrent Pharmaceuticals

BSE:500420

₹1.1t

Lupin

BSE:500257

₹911.9b

Cipla

NSEI:CIPLA

₹1.2t

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Dr. Reddy's Laboratories
과거 주가
현재 주가₹1,191.95
52주 최고치₹1,421.49
52주 최저치₹1,074.00
베타0.33
11개월 변경-6.49%
3개월 변경 사항-15.24%
1년 변경 사항2.96%
33년 변화27.82%
5년 변화107.54%
IPO 이후 변화1,237.39%

최근 뉴스 및 업데이트

Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Nov 23
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Nov 08
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Nov 01
Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Recent updates

Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Nov 23
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Nov 08
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Nov 01
Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Oct 14
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Aug 19
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Aug 01
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Jul 30
The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Jul 12
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Jun 23
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Jun 20
Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

May 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

May 06
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Apr 18
There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 02
Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Jan 19
Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Jan 01
Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Oct 03
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Jul 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Jun 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Jun 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

May 27
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

May 13
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Apr 11
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dec 05
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

주주 수익률

DRREDDYIN PharmaceuticalsIN 마켓
7D-0.3%0.8%2.9%
1Y3.0%42.1%28.9%

수익률 대 산업: DRREDDY 지난 1년 동안 42.1 %를 반환한 Indian Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: DRREDDY 지난 1년 동안 28.9 %를 반환한 Indian 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is DRREDDY's price volatile compared to industry and market?
DRREDDY volatility
DRREDDY Average Weekly Movement2.5%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.0%

안정적인 주가: DRREDDY 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: DRREDDY 의 주간 변동성( 2% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
198427,048Erez Israeliwww.drreddys.com

닥터 레디 래버러토리스 리미티드는 자회사와 함께 전 세계에서 통합 제약 회사로 운영되고 있습니다. 이 회사는 글로벌 제네릭, 제약 서비스 및 활성 성분(PSAI), 기타 부문을 통해 운영됩니다. 회사의 글로벌 제네릭 부문은 브랜드 이름으로 판매되거나 브랜드 제형과 치료적 동등성이 있는 제네릭 완제품으로 판매되는 처방약 및 일반의약품을 제조 및 판매하며 생물학적 제제 사업에도 참여하고 있습니다.

Dr. Reddy's Laboratories Limited 기본 사항 요약

Dr. Reddy's Laboratories 의 수익과 매출은 시가총액과 어떻게 비교하나요?
DRREDDY 기본 통계
시가총액₹993.43b
수익(TTM)₹53.33b
수익(TTM)₹299.87b

18.6x

P/E 비율

3.3x

P/S 비율

DRREDDY 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
DRREDDY 손익 계산서(TTM)
수익₹299.87b
수익 비용₹122.07b
총 이익₹177.80b
기타 비용₹124.47b
수익₹53.33b

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)64.03
총 마진59.29%
순이익 마진17.79%
부채/자본 비율14.2%

DRREDDY 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

0.7%

현재 배당 수익률

12%

지급 비율